Emtricitabine Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Emtricitabine Capsule (capsule) from Gilead Sciences, Inc. with status To Be Discontinued. The shortage was first posted on 06/17/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Gilead Sciences, Inc.
- Package NDC
- 61958-0601-1
- Dosage Form
- Capsule
- Presentation
- Emtriva, Capsule, 200 mg (NDC 61958-0601-1)
- Initial Posting
- 06/17/2026
- Revised Date